The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Abstract
Plasminogen activator inhibitor 1 (PAI‐1) is believed to control proteolytic activity and cell migration during angiogenesis. We previously demonstrated in vivo that this inhibitor is necessary for optimal tumor invasion and vascularization. We also showed that PAI‐1 angiogenic activity is associated with its control of plasminogen activation but not with the regulation of cell‐matrix interaction. To dissect the role of the various components of the plasminogen activation system during angiogenesis, we have adapted the aortic ring assay to use vessels from gene‐inactivated mice. The single deficiency of tPA, uPA, or uPAR, as well as combined deficiencies of uPA and tPA, did not dramatically affect microvessel formation. Deficiency of plasminogen delayed microves‐sel outgrowth. Lack of PAI‐1 completely abolished angio‐genesis, demonstrating its importance in the control of plasmin‐mediated proteolysis. Microvessel outgrowth from PAI‐1 ‐/‐ aortic rings could be restored by adding exogenous PAI‐1 (wild‐type serum or purified recombi‐nant PAI‐1). Addition of recombinant PAI‐1 led to a bell‐shaped angiogenic response clearly showing that PAI‐1 is proangiogenic at physiological concentrations and antiangiogenic at higher levels. Using specific PAI‐1 mutants, we could demonstrate that PAI‐1 promotes an‐giogenesis at physiological (nanomolar) concentrations through its antiproteolytic activity rather than by interacting with vitronectin.—Devy, L., Blacher, S., Grignet‐Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., Noèl, A., Foidart, J. M. The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16, 147–154 (2002)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Voyta, J. C., Via, D. P., Butterfield, C. E., & Zetter, B. R. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.6.2034 · Cited by 1,239
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Self-citationAbsence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Self-citationThe serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Montesano, R., Orci, L., & Vassalli, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.5.1648 · Cited by 647
Nicosia, R. F., & Ottinetti, A. (1990) · PubMed · Cited by 597
Pepper, M. S., Belin, D., Montesano, R., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.743 · Cited by 453
Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brünner, N., Jänicke, F., Gelder, M. E. M., Henzen-Logmans, S. C., et al. (2000) · PubMed · Cited by 419
Bajou, K., Masson, V., Gerard, R. D., Schmitt, P. M., Albert, V., Praus, M., Lund, L. R., Frandsen, T. L., Brunner, N., Dano, K., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.777 · Cited by 314
Self-citationWaltz, D. A., Natkin, L. W., Fujita, R. M., Wei, Y., & Chapman, H. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119521 · Cited by 288
Functional overlap between two classes of matrix-degrading proteases in wound healing
Lund, L. R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4645 · Cited by 270
uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?
Blasi, F. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01121-3 · Cited by 243
Plasminogen Deficiency Differentially Affects Recruitment of Inflammatory Cell Populations in Mice
Ploplis, V. A., French, E. L., Carmeliet, P., Collen, D., & Plow, E. F. (1998) · Blood · doi:10.1182/blood.v91.6.2005 · Cited by 227
Self-citationGutierrez, L. S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., & Castellino, F. (2000) · PubMed · Cited by 217
Activation of plasminogen by human plasma kallikrein
Colman, R. W. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90278-2 · Cited by 216
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
Stefansson, S., Petitclerc, E., Wong, M. K., McMahon, G. A., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007609200 · Cited by 177
Development and Disease in Proteinase-Deficient Mice
Carmeliet, P., & Collen, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00122-4 · Cited by 175
Self-citationCarmeliet, P., & Collen, D. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_7 · Cited by 167
Self-citationSoff, G. A., Sanderowitz, J., Gately, S. T., Verrusio, E., Weiss, I., Brem, S. S., & Kwaan, H. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118323 · Cited by 156
Regulation of cell adhesion by PAI‐1
Loskutoff, D. J., Curriden, S. A., Hu, G., & Deng, G. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01526.x · Cited by 155
Histotypic angiogenesis in vitro: Light microscopic, ultrastructural, and radioautographic studies
Nicosia, R. F., Tchao, R., & Leighton, J. (1982) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02810077 · Cited by 139
Improved quantification of angiogenesis in the rat aortic ring assay
Blacher, S., Devy, L., Burbridge, M. F., Roland, G., Tucker, G., Noël, A., & Foidart, J. (2001) · Angiogenesis · doi:10.1023/a:1012251229631 · Cited by 105
Self-citationBehringer, R. R., Crotty, D. A., Tennyson, V. M., Brinster, R. L., Palmiter, R. D., & Wolgemuth, D. J. (1993) · Development · doi:10.1242/dev.117.3.823 · Cited by 98
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
Lambert, V., Munaut, C., Noël, A., Frankenne, F., Bajou, K., Gerard, R. D., Carmeliet, P., Defresne, M. P., Foidart, J., & Rakic, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0393com · Cited by 98
Self-citationMiles, L. A., Greengard, J. S., & Griffin, J. H. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90244-x · Cited by 87
Cited by
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Self-citationRadiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Angiogenesis modulates adipogenesis and obesity
Cao, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32239 · Cited by 736
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 487
Use of the mouse aortic ring assay to study angiogenesis
Baker, M., Robinson, S. D., Lechertier, T., Barber, P. R., Tavora, B., D'Amico, G., Jones, D. T., Vojnovic, B., & Hodivala-Dilke, K. (2012) · Nature Protocols · doi:10.1038/nprot.2011.435 · Cited by 477
Metadata
- Authors
- Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., NoëL, A., & Foidart, J.-M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 16
- Issue
- 2
- Pages
- 147-154
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2096487443
- Cited by
- 280
- References
- 27
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.